Literature DB >> 29256326

Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer.

Mark A Ellis1, Evan M Graboyes1, Amy E Wahlquist2, David M Neskey1, John M Kaczmar3, Heather K Schopper1, Anand K Sharma4, Patrick F Morgan1, Shaun A Nguyen1, Terry A Day1.   

Abstract

Objective The goal of this study is to determine the effect of primary surgery vs radiotherapy (RT) on overall survival (OS) in patients with early stage oral cavity squamous cell carcinoma (OCSCC). In addition, this study attempts to identify factors associated with receiving primary RT. Study Design Retrospective cohort study. Setting National Cancer Database (NCDB, 2004-2013). Subjects and Methods Reviewing the NCDB from 2004 to 2013, patients with early stage I to II OCSCC were identified. Kaplan-Meier estimates of survival, Cox regression analysis, and propensity score matching were used to examine differences in OS between primary surgery and primary RT. Multivariable logistic regression analysis was performed to identify factors associated with primary RT. Results Of the 20,779 patients included in the study, 95.4% (19,823 patients) underwent primary surgery and 4.6% (956 patients) underwent primary RT. After adjusting for covariates, primary RT was associated with an increased risk of mortality (adjusted hazard ratio [aHR], 1.97; 99% confidence interval [CI], 1.74-2.22). On multivariable analysis, factors associated with primary RT included age ≥70 years, black race, Medicaid or Medicare insurance, no insurance, oral cavity subsite other than tongue, clinical stage II disease, low-volume treatment facilities, and earlier treatment year. Conclusion Primary RT for early stage OCSCC is associated with increased mortality. Approximately 5% of patients receive primary RT; however, this percentage is decreasing. Patients at highest risk for receiving primary RT include those who are elderly, black, with public insurance, and treated at low-volume facilities.

Entities:  

Keywords:  NCCN guidelines; National Cancer Database; oral cavity cancer; overall survival; radiotherapy; squamous cell carcinoma; surgery

Mesh:

Year:  2017        PMID: 29256326     DOI: 10.1177/0194599817746909

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

1.  Making the Best of Limited Resources: Improving Outcomes in Head and Neck Cancer.

Authors:  Johannes J Fagan; Vanita Noronha; Evan Michael Graboyes
Journal:  Am Soc Clin Oncol Educ Book       Date:  2021-03

2.  Current-Smoking-Related COPD or COPD With Acute Exacerbation is Associated With Poorer Survival Following Oral Cavity Squamous Cell Carcinoma Surgery.

Authors:  Jiaqiang Zhang; Wei-Chun Lin; Kuo-Chin Chiu; Szu-Yuan Wu
Journal:  Chronic Obstr Pulm Dis       Date:  2022-04-29

3.  Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000.

Authors:  Sarah Schimansky; Samantha Lang; Rhona Beynon; Christopher Penfold; Amy Davies; Andrea Waylen; Steve Thomas; Miranda Pring; Michael Pawlita; Tim Waterboer; Andy Ness
Journal:  Head Neck       Date:  2018-12-14       Impact factor: 3.147

4.  Prognostic factors on surgically and non-surgically treated oral squamous cell carcinoma: Advances in survival in fifteen years of follow up.

Authors:  Paulo-Goberlânio-de Barros Silva; José-Vitor-Mota Lemos; Marcela-Maria-Fontes Borges; Talita-Jordânia-Rocha do Rêgo; Thinali-Sousa Dantas; Carlos-Heli-Bezerra Leite; Marcos-Venício-Alves Lima; Maria-do Perpétuo-Socorro-Saldanha Cunha; Fabrício-Bitu Sousa
Journal:  J Clin Exp Dent       Date:  2021-03-01

5.  SAHA Overcomes 5-FU Resistance in IFIT2-Depleted Oral Squamous Cell Carcinoma Cells.

Authors:  Prabha Regmi; Kuo-Chu Lai; Chung-Ji Liu; Te-Chang Lee
Journal:  Cancers (Basel)       Date:  2020-11-26       Impact factor: 6.639

Review 6.  Is There Still a Place for Brachytherapy in the Modern Treatment of Early-Stage Oral Cancer?

Authors:  Luboš Tuček; Milan Vošmik; Jiří Petera
Journal:  Cancers (Basel)       Date:  2022-01-03       Impact factor: 6.639

7.  Population-based comparative survival analysis of surgery with or without adjuvant radiotherapy and non-operative primary radiotherapy in patients with early-stage oral tongue squamous cell carcinoma.

Authors:  Yu Jin Lim; Moonkyoo Kong
Journal:  PLoS One       Date:  2021-11-11       Impact factor: 3.240

Review 8.  Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.

Authors:  Andrew T Day; David J Sher; Rebecca C Lee; John M Truelson; Larry L Myers; Baran D Sumer; Lenka Stankova; Brittny N Tillman; Randall S Hughes; Saad A Khan; Eli A Gordin
Journal:  Oral Oncol       Date:  2020-04-06       Impact factor: 5.337

9.  Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost.

Authors:  Tomáš Blažek; Zuzana Zděblová Čermáková; Lukáš Knybel; Pavel Hurník; Jan Štembírek; Kamila Resová; Tereza Paračková; Martin Formánek; Jakub Cvek; Renata Soumarová
Journal:  Radiat Oncol       Date:  2021-06-29       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.